Thursday, 28 November, 2013 - 11:52
Biotech sector haunted by 'valley of death'
FEATURE: The state’s biotechnology sector is heating up as investors look for the next wave of investment opportunities amid waning resources investment.
Liddy McCall has over 20 years of experience as a founder, investor, and in management of early-stage startups.
Ms McCall established Tessitura to incubate startup businesses. Tessitura combines scientific and commercial experience to transform research projects into operating biotechnology companies. She also co-founded early-state venture fund Yuuwa Capital LP, iCeutica, Dimerix and Argus Biomedical.
Ms McCall’s prior experience as an associate director of the corporate advisory group at Macquarie Bank has provided the skills to manage the complex aspects of corporate mergers and acquisitions domestically and in an international context. Tessitura has extended her skills further by requiring her to undertake similar tasks within the constraints of a startup environment with limited financial and management resources.
For over a year, two research projects have progressed to spin-out companies that employ six full-time scientific researchers, sub-contract two scientific researchers and support more than six consultants. They have been awarded federal grants and have attracted significant international and interstate investment in addition to local funding.
Name | Current company |
---|
Rank | Company | 1 Yr | 5 Yr |
---|---|---|---|
1155th | Zuleika Gold">Zuleika Gold | -23.29% | -4.38% |
1156th | Weebit Nano">Weebit Nano | -23.33% | 45.19% |
1157th | AdAlta">AdAlta | -23.35% | -30.08% |
1158th | Enero Group">Enero Group | -23.46% | -4.56% |
1159th | Minbos Resources">Minbos Resources | -23.51% | 23.91% |
![]() |
NEWS: Tagged in Board moves October 24, 2024 | 24 Oct 2024 |
![]() |
NEWS: Tagged in Charity venture fund targets research | 16 Oct 2024 |
![]() |
NEW ROLE: , Realside Property | 21 Jun 2024 |
![]() |
NEWS: Tagged in Promise of new era in venture capital | 29 Mar 2023 |
![]() |
NEW ROLE: Board Member, Ear Science Institute Australia | 10 Aug 2021 |
![]() |
NEW ROLE: Non-Executive Director, The Tailor Made Spirits Company | 10 Aug 2021 |
![]() |
NEW ROLE: Non-Executive Director, Agworld | 10 Aug 2021 |
![]() |
NEW ROLE: Non-Executive Director, Argenica Therapeutics | 10 Aug 2021 |
![]() |
NEWS: Tagged in Biotech sector haunted by 'valley of death' | 19 Aug 2020 |
FEATURE: The state’s biotechnology sector is heating up as investors look for the next wave of investment opportunities amid waning resources investment.
FEATURE: Biotech and IT companies are enjoying renewed investor interest, but these innovative businesses are facing a changing capital raising market featuring less government support and, in Perth, a drastic shift in the venture capital sector.
Melbourne-based biotech Fitgenes has brought control of its extensive health and nutrition clinics in-house.
SPECIAL REPORT: Tech startups in WA can raise capital if they know where to look and how to ask, a Perth seminar was told.
The state government has appointed an industry reference group to develop a growth plan for WA’s health and medical life sciences sector to be chaired by Peter Klinken.
The recent $100 million sale of Agworld is a badge of success for WA tech but also reveals the sector’s limitations.
The commercial side of life sciences may have reached a critical mass in WA.
Three new local funds proposing to focus on early-stage investment are raising expectations.
A not-for-profit investment vehicle aims to build a $100 million fund for WA investment.
Today’s board moves wrap includes Keith Rumble, Liddy McCall and Adrian Smith.
Access to our data for Liddy McCall is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Liddy McCall is linked to 8 organisations which are included in 2 lists - Public Companies - non WA and Charitable Organisations.
To see the data you will need to Subscribe.